Simpson, Ericka

Publications

Sort by

Co-Author Network

selected publications

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis. Neurology. 2016 Academic Article GET IT
Times cited: 91
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2015 Academic Article GET IT
Times cited: 23
Acute Onset of Guillain-Barré Syndrome After Elective Spinal Surgery. 2015 GET IT
Times cited: 14
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science (New York, N.Y.). 2015 Academic Article GET IT
Times cited: 687
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 2014 Academic Article GET IT
Times cited: 167
Seeking a measure of clinically meaningful change in ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2014 Academic Article GET IT
Times cited: 11
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis. Journal of clinical pharmacology. 2014 Academic Article GET IT
Times cited: 18
TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA neurology. 2014 Academic Article GET IT
Times cited: 204
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet (London, England). 2014 Academic Article GET IT
Times cited: 187
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PloS one. 2013 Academic Article GET IT
Times cited: 90
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. The Lancet. Neurology. 2013 Academic Article GET IT
Times cited: 483
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology. 2011 Academic Article GET IT
Times cited: 63
Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4. Brain : a journal of neurology. 2011 Academic Article GET IT
Times cited: 98
Does apolipoprotein E genotype modify the clinical expression of ALS?. European journal of neurology. 2010 Academic Article GET IT
Times cited: 15
A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010 Academic Article GET IT
Times cited: 105
Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010 Review GET IT
Times cited: 63
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. European journal of neurology. 2010 Academic Article GET IT
Times cited: 73
Association between dysarthria and cognitive impairment in ALS: A prospective study. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010 Academic Article GET IT
Times cited: 18
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology. 2008 Academic Article GET IT
Times cited: 210
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology. 2008 Academic Article GET IT
Times cited: 114
Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. 2008 GET IT
Times cited: 69
Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery. PloS one. 2007 Academic Article GET IT
Times cited: 15
Whole-genome analysis of sporadic amyotrophic lateral sclerosis. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 212
Predictability of disease progression in amyotrophic lateral sclerosis. Muscle & nerve. 2006 Academic Article GET IT
Times cited: 46
The value of database controls in pilot or futility studies in ALS. Neurology. 2006 Academic Article GET IT
Times cited: 16
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Archives of neurology. 2006 Academic Article GET IT
Times cited: 68
"Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers" by Lo Coco G, Lo Coco D, Cicero V, Oliveri A, Lo Verso G, Piccolo F, La Bella V. Journal of the neurological sciences. 2005 Editorial Article GET IT
Times cited: 2
Antioxidant treatment for amyotrophic lateral sclerosis. The Lancet. Neurology. 2005 Review GET IT
Times cited: 2
Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. Journal of neuropathology and experimental neurology. 2004 Academic Article GET IT
Times cited: 135
Design using historical controls. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2004 Academic Article GET IT
Times cited: 2
Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology. 2004 Academic Article GET IT
Times cited: 258
HFE mutations are not strongly associated with sporadic ALS. Neurology. 2004 Academic Article GET IT
Times cited: 39
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Annals of neurology. 2004 Academic Article GET IT
Times cited: 435
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Current opinion in rheumatology. 2003 Review GET IT
Times cited: 90
PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. Journal of neuropathology and experimental neurology. 2003 Academic Article GET IT
Times cited: 51
Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. A central role for calcium. Advances in neurology. 2002 Review GET IT
Times cited: 12
Activated microglia: the silent executioner in neurodegenerative disease?. Current neurology and neuroscience reports. 2001 Review GET IT
Times cited: 16
Middle cerebral artery vasculitis and stroke after varicella in a young adult. 1998 GET IT
Times cited: 11

more ...

less ...

Background

education and training

M.D., University of Texas Medical School, Houston 1995
B.S., Rice University 1991

Contact

full name

Ericka Simpson

VIVO Weill Cornell Medical College

Ericka Simpson Professor of Clinical Neurology

Publications

selected publications

Background

education and training

Contact

full name